microscopic polyangiitis

GPTKB entity

Statements (50)
Predicate Object
gptkbp:instance_of gptkb:musician
gptkbp:bfsLayer 4
gptkbp:bfsParent gptkb:Rituxan
gptkbp:affects small blood vessels
gptkbp:associated_with ANCA
gptkbp:clinical_trial ongoing research
new therapies
biologic agents
gptkbp:complications chronic kidney disease
lung damage
nerve damage
gptkbp:current_use gptkb:granulomatosis_with_polyangiitis
gptkb:eosinophilic_granulomatosis_with_polyangiitis
gptkbp:education recognizing symptoms
importance of early diagnosis
adherence to treatment
gptkbp:first_described_by gptkb:1980s
gptkbp:gender more common in men
https://www.w3.org/2000/01/rdf-schema#label microscopic polyangiitis
gptkbp:is_a_route_for inflammation of blood vessels
immune system attack
gptkbp:is_involved_in gptkb:local_chapters
online resources
available for patients
gptkbp:is_popular_in rare
gptkbp:premiered_on adults
gptkbp:risk_factor gptkb:healthcare_organization
autoimmune diseases
genetic predisposition
gptkbp:social_responsibility gptkb:polyarteritis_nodosa
variable
blood tests
urinalysis
biopsy
lupus nephritis
more common in certain regions
depends on severity
early treatment improves outcomes
Ig A vasculitis
MPO-ANCA
associated with certain infections
higher incidence in older adults
gptkbp:symptoms skin lesions
kidney damage
pulmonary hemorrhage
gptkbp:treatment gptkb:cyclophosphamide
gptkb:rituximab
corticosteroids
plasma exchange
immunosuppressants